gallery 1
Impurities Profile Management in the Pharmaceutical Product Life Cycle
September 20, 2017 | Toronto, Canada
October 18, 2017 | Montreal, Canada
Who will benefit:
    Participants in this seminar will:

    • Understand the ICH guidance and USP regulations associated with product manufacture and impurities

    • Understand basic methodology for identifying related substance vs. exogenous impurities

    • Associate impurity characterization with the product development timeline in a phase-appropriate way

    • Learn about newer analytical technologies and their impact on impurity study

    • Develop a holistic understanding of impurity management across the product development life cycle

    Who Should Attend:

    QA, QC, RA, and analytical R&D professionals from Lifescience industry (Pharma, Veterinary, NHP)